SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0000059478-19-000335
Filing Date
2019-12-20
Accepted
2019-12-20 10:34:04
Documents
15
Period of Report
2019-12-20
Items
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K bylawsamendment8-k12x1.htm   iXBRL 8-K 65973
2 EXHIBIT 3.1 elilillyandcompanybyla.htm EX-3.1 223281
  Complete submission text file 0000059478-19-000335.txt   561691

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT lly-20191220.xsd EX-101.SCH 6146
4 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT lly-20191220_cal.xml EX-101.CAL 613
5 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT lly-20191220_def.xml EX-101.DEF 18477
6 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT lly-20191220_lab.xml EX-101.LAB 42907
7 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT lly-20191220_pre.xml EX-101.PRE 20814
8 EXTRACTED XBRL INSTANCE DOCUMENT bylawsamendment8-k12x1_htm.xml XML 13770
Mailing Address LILLY CORPORATE CENTER DROP CODE 1094 INDIANAPOLIS IN 46285
Business Address LILLY CORPORATE CTR DROP CODE 1094 INDIANAPOLIS IN 46285 3172762000
ELI LILLY & Co (Filer) CIK: 0000059478 (see all company filings)

IRS No.: 350470950 | State of Incorp.: IN | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-06351 | Film No.: 191298146
SIC: 2834 Pharmaceutical Preparations